William J. Kostuk

London, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.

Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.

Journal: The American journal of cardiology

Published: May 01, 2020

Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.

Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.

Journal: Journal of the American College of Cardiology

Published: September 10, 2018

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.

Journal: Journal of the American College of Cardiology

Published: June 08, 2018

Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Journal: Circulation. Cardiovascular quality and outcomes

Published: May 28, 2017

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.

Journal: The New England journal of medicine

Published: November 13, 2015

Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).

Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).

Journal: The American journal of cardiology

Published: March 18, 2015

Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease.

Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease.

Journal: The Canadian journal of cardiology

Published: May 15, 2014

Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.

Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.

Journal: JACC. Cardiovascular interventions

Published: August 21, 2013

Single-stage hybrid coronary revascularization with long-term follow-up.

Single-stage hybrid coronary revascularization with long-term follow-up.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: August 20, 2013

Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial.

Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial.

Journal: Stroke

Published: July 25, 2013

Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.

Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.

Journal: American heart journal

Published: April 28, 2013

Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Journal: Journal of the American College of Cardiology

Published: March 25, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026